Skip to content

CYTO

Altamira Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · BM

$0.30
+0.00%
Ask drillr

Latest reported

Last report date
Sep 24, 2024
EPS actual
-$1.99
EPS estimate
-$2.38
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
1
EPS misses (12Q)
2
EPS in line (12Q)
0
Avg surprise (4Q)
-369.4%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Sep 24, 2024-$2.38-$1.99Beat 16.60%
May 16, 2023-$3.13
Nov 30, 2022-$111
Apr 12, 2022$8.6K
Mar 31, 2022-$115$157.1K
Jun 30, 2021-$117
Mar 31, 2021-$115
Sep 17, 2020-$123
Apr 16, 2020-$32-$85Miss -165.98%-$57.1K
Mar 31, 2020-$119
Aug 15, 2019-$16-$169Miss -958.79%
Mar 14, 2019-$497$1.3M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 16, 2025